Number of shares and votes in Active Biotech

(Thomson Reuters ONE) -


The number of shares and votes in Active Biotech has changed as a result of the
rights issue that was made during the end of 2014.

Today, the last trading day of the month, there are in total 89,908,298 shares
and votes in Active Biotech.

For further information, please contact:
Hans Kolam, CFO
Tel: +46 (0)46 19 20 44
E-mail: hans.kolam(at)activebiotech.com


Active Biotech AB (publ) (Nasdaq Stockholm: ACTI) is a biotechnology company
with focus on neurodegenerative diseases and cancer. Projects in pivotal phase
are laquinimod, an orally administered small molecule with unique
immunomodulatory properties for the treatment of multiple sclerosis, and
tasquinimod, an oral immunomodulatory, anti-metastatic substance for the
treatment of prostate cancer. The objective of the preclinical ISI project is to
produce new, patentable chemical compounds for treatment of diseases in the
company's focus areas. Please visit www.activebiotech.com for more information.

Active Biotech is required to publish the information contained in this press
release in accordance with the Swedish Securities Market Act. This information
was provided to the media for publication at
8:30 am CET on January 30, 2015.


Number of shares and votes in Active Biotech:
http://hugin.info/1002/R/1890086/669119.pdf



This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Active Biotech via GlobeNewswire
[HUG#1890086]

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 30.01.2015 - 08:30 Uhr
Sprache: Deutsch
News-ID 368066
Anzahl Zeichen: 2008

contact information:
Town:

LUND

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 198 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Number of shares and votes in Active Biotech"
steht unter der journalistisch-redaktionellen Verantwortung von

Active Biotech (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Primary endpoint reached in Active Biotech's TASQ Phase II clinical trial i ...

Lund, Sweden, December 14, 2009 - A first analysis of the primary endpoint based on data from at least six months' treatment of more than 200 patients, has been performed in Active Biotech AB's (NASDAQ OMX Nordic: ACTI) ongoing Phase II cli ...

Active Biotech's election committee appointed ...

In accordance with a decision made by the Annual General Meeting held on May 7, 2009, the Election Committee shall comprise the representatives for the three largest shareholders on September 30 and the Board Chairman. For the 2010 Annual General ...

Active Biotech AB Interim Report, January - September 2009 ...

* Laquinimod -- new data presented at ECTRIMS * 57-57 -- exploratory clinical trial in progress * RhuDex(TM) -- clinical development to continue following feedback from UK MHRA * ANYARA -- complete Phase I data published * TASQ -- complete Phase I ...

Alle Meldungen von Active Biotech